Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidel

Showing results (651-660 of 715) with videos related to

Pageof 72
Sort By:
Plos Pathogens|June 5, 2020
Potent, specific MEPicides for treatment of zoonotic staphylococciRachel L Edwards, Isabel Heueck, Soon Goo Lee, et al.
Nature Communications|June 17, 2020
Hematopoietic stem and progenitor cell-restricted Cdx2 expression induces transformation to myelodysplasia and acute leukemiaTherese Vu, Jasmin Straube, Amy H Porter, et al.
Leukemia|August 27, 2015
NOX4-driven ROS formation mediates PTP inactivation and cell transformation in FLT3ITD-positive AML cellsA K Jayavelu, J P Müller, R Bauer, et al.
Hematological Oncology|May 18, 2017
Efficacy and safety of ruxolitinib in intermediate-1 IPSS risk myelofibrosis patients: Results from an independent studyFrancesca Palandri, Mario Tiribelli, Giulia Benevolo, et al.
Leukemia|April 28, 2025
Prognostic impact of clonal representation of myelodysplasia-related gene mutations in acute myeloid leukemiaRabea Mecklenbrauck, Nora Borchert, Razif Gabdoulline, et al.
Nature Communications|May 4, 2019
Clonal evolution patterns in acute myeloid leukemia with NPM1 mutationSibylle Cocciardi, Anna Dolnik, Silke Kapp-Schwoerer, et al.
Nature Communications|August 23, 2017
Activated protein C protects from GvHD via PAR2/PAR3 signalling in regulatory T-cellsSatish Ranjan, Alexander Goihl, Shrey Kohli, et al.
Leukemia|April 29, 2025
The protein deacetylase HDAC10 controls DNA replication in malignant lymphoid cellsAndreas O Mieland, Giuseppe Petrosino, Mario Dejung, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 25, 2025
Disease Phenotype Significantly Influences the Outcome After Discontinuation of Ruxolitinib in Chronic Phase MyelofibrosisFrancesca Palandri, Massimo Breccia, Erika Morsia, et al.
Cancers|August 27, 2021
Kidney Dysfunction Is Associated with Thrombosis and Disease Severity in Myeloproliferative Neoplasms: Implications from the German Study Group for MPN BioregistryJudith Gecht, Ioannis Tsoukakis, Kim Kricheldorf, et al.
Pageof 72

Showing results (651-660 of 715) with videos related to

Sort By:
Pageof 72
Plos Pathogens|June 5, 2020
Potent, specific MEPicides for treatment of zoonotic staphylococciRachel L Edwards, Isabel Heueck, Soon Goo Lee, et al.
Nature Communications|June 17, 2020
Hematopoietic stem and progenitor cell-restricted Cdx2 expression induces transformation to myelodysplasia and acute leukemiaTherese Vu, Jasmin Straube, Amy H Porter, et al.
Leukemia|August 27, 2015
NOX4-driven ROS formation mediates PTP inactivation and cell transformation in FLT3ITD-positive AML cellsA K Jayavelu, J P Müller, R Bauer, et al.
Hematological Oncology|May 18, 2017
Efficacy and safety of ruxolitinib in intermediate-1 IPSS risk myelofibrosis patients: Results from an independent studyFrancesca Palandri, Mario Tiribelli, Giulia Benevolo, et al.
Leukemia|April 28, 2025
Prognostic impact of clonal representation of myelodysplasia-related gene mutations in acute myeloid leukemiaRabea Mecklenbrauck, Nora Borchert, Razif Gabdoulline, et al.
Nature Communications|May 4, 2019
Clonal evolution patterns in acute myeloid leukemia with NPM1 mutationSibylle Cocciardi, Anna Dolnik, Silke Kapp-Schwoerer, et al.
Nature Communications|August 23, 2017
Activated protein C protects from GvHD via PAR2/PAR3 signalling in regulatory T-cellsSatish Ranjan, Alexander Goihl, Shrey Kohli, et al.
Leukemia|April 29, 2025
The protein deacetylase HDAC10 controls DNA replication in malignant lymphoid cellsAndreas O Mieland, Giuseppe Petrosino, Mario Dejung, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 25, 2025
Disease Phenotype Significantly Influences the Outcome After Discontinuation of Ruxolitinib in Chronic Phase MyelofibrosisFrancesca Palandri, Massimo Breccia, Erika Morsia, et al.
Cancers|August 27, 2021
Kidney Dysfunction Is Associated with Thrombosis and Disease Severity in Myeloproliferative Neoplasms: Implications from the German Study Group for MPN BioregistryJudith Gecht, Ioannis Tsoukakis, Kim Kricheldorf, et al.
Pageof 72